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Demiralp, 2005; Tekell et al., 2005; Flynn et al., 2008), suggesting 
that gamma power alterations do not reflect an inability to engage 
in higher frequency oscillations, but rather an inability to appro-
priately modulate this activation. Furthermore, the local nature of 
gamma oscillations is discrepant with the scale of network integra-
tion. Gamma synchronization is typically observed in intra-area 
assemblies where cells are separated by few synaptic connections, 
making high-frequency oscillations unlikely to mediate integra-
tion between distal structures (von Stein and Sarnthein, 2000). In 
contrast, low-frequency oscillations (∼1–20 Hz), are well-suited 
to coordinate long-distance communication as they are robust 
to conduction delays in polysynaptic pathways and are observed 
in more global, inter-area interactions, e.g., top–down process-
ing (von Stein and Sarnthein, 2000) and attentional modulation 
(Lakatos et al., 2008).
It is hypothesized that lower-frequency oscillations coordinate 
information between areas by modulating excitability of local 
ensembles (von Stein and Sarnthein, 2000; Fries, 2005; Lisman 
and Buzsáki, 2008). Modulation of high-frequency amplitude by 
IntroductIon
The clinical presentation of schizophrenia includes diverse symp-
toms involving perceptual, cognitive and emotional impairments. 
These abnormalities implicate extended brain networks, suggesting 
that the pathophysiology of schizophrenia involves impaired coor-
dination between regions, rather than localized deficits (Andreasen 
et al., 1998; Friston, 1998). However, the neural mechanisms 
underlying normal network integration, and their possible defi-
cits in schizophrenia, remain uncertain. Past studies have focused 
on the role of neuronal oscillations, particularly in the gamma 
band (∼30–100 Hz), that reflect the paced synchronous activity of 
local ensembles and are linked with many cognitive and sensory 
processes (Lee et al., 2003; Herrmann and Demiralp, 2005; Fries 
et al., 2007; Gonzalez-Burgos and Lewis, 2008; Uhlhaas et al., 2008). 
Reports of reduced gamma oscillations in schizophrenia have lead 
to speculations of altered cortical circuitry less able to synchro-
nize at higher rhythms (Lee et al., 2003; Symond et al., 2005; Cho 
et al., 2006), however some studies report no group differences 
(Spencer et al., 2008) or even patient increases (Herrmann and 
Components of cross-frequency modulation in health and 
disease
Elena A. Allen1*, Jingyu Liu1,2, Kent A. Kiehl1,3,4, Joel Gelernter5,6,7, Godfrey D. Pearlson7, 8,  
Nora I. Perrone-Bizzozero4 and Vince D. Calhoun1,2,4,7,8
1  The Mind Research Network, Albuquerque, NM, USA
2  Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM, USA
3  Department of Psychology, University of New Mexico, Albuquerque, NM, USA
4  Department of Neurosciences, School of Medicine, University of New Mexico, Albuquerque, NM, USA
5  Department of Genetics, Yale University, New Haven, CT, USA
6  Department of Neurobiology, Yale University, New Haven, CT, USA
7  Department of Psychiatry, Yale University, New Haven, CT, USA
8  Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA
The cognitive deficits associated with schizophrenia are commonly believed to arise from 
the abnormal temporal integration of information, however a quantitative approach to assess 
network coordination is lacking. Here, we propose to use cross-frequency modulation (cfM), 
the dependence of local high-frequency activity on the phase of widespread low-frequency 
oscillations, as an indicator of network coordination and functional integration. In an exploratory 
analysis based on pre-existing data, we measured cfM from multi-channel EEG recordings 
acquired while schizophrenia patients (n = 47) and healthy controls (n = 130) performed an auditory 
oddball task. Novel application of independent component analysis (ICA) to modulation data 
delineated components with specific spatial and spectral profiles, the weights of which showed 
covariation with diagnosis. Global cfM was significantly greater in healthy controls (F1,175 = 9.25, 
P < 0.005), while modulation at fronto-temporal electrodes was greater in patients (F1,175 = 17 .5, 
P < 0.0001). We further found that the weights of schizophrenia-relevant components were 
associated with genetic polymorphisms at previously identified risk loci. Global cfM decreased 
with copies of 957C allele in the gene for the dopamine D2 receptor (r = −0.20, P < 0.01) across 
all subjects. Additionally, greater “aberrant” fronto-temporal modulation in schizophrenia patients 
was correlated with several polymorphisms in the gene for the α2-subunit of the GABAA receptor 
(GABRA2) as well as the total number of risk alleles in GABRA2 (r = 0.45, P < 0.01). Overall, our 
results indicate great promise for this approach in establishing patterns of cfM in health and 
disease and elucidating the roles of oscillatory interactions in functional connectivity.
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doi: 10.3389/fnsys.2011.00059low-frequency phase, known as cross-frequency modulation (cfM), 
permits greater gamma synchronization during specific phases of 
the slower rhythm, theoretically allowing effective interactions 
between neurons with similar phase preferences (von Stein and 
Sarnthein, 2000; Fries, 2005; Lisman and Buzsáki, 2008). The phase 
of low-frequency oscillations has been noted to affect not only 
rhythmic gamma activity, but also the spiking rates of individual 
neurons (Canolty et al., 2010) and non-rhythmic broadband power 
(He et al., 2010; Miller et al., 2010), which has been associated 
with multi-unit activity (Ray and Maunsell, 2011). CfM has been 
observed in numerous brain regions, is associated with sensory 
perception and task performance, and is emerging as a robust 
organizational principal of neural signals (Lakatos et al., 2005, 
2008; Mormann et al., 2005; Canolty et al., 2006; Demiralp et al., 
2007; Cohen et al., 2009; Maris et al., 2011) and complex systems 
in general (He et al., 2010).
Given the symptomology of schizophrenia and the proposed 
role of cfM in inter-areal communication, we hypothesized that 
patterns of cfM would be significantly altered in schizophrenia 
patients. Departing from previous studies where investigation scope 
is limited to particular regions or phase–amplitude relationships 
due to the combinatorial nature of oscillatory interactions and 
complexity of data analysis, we propose a new approach for the 
thorough exploration of cfM that is also amenable to compara-
tive analysis. We utilize independent component analysis (ICA) to 
discover fundamental patterns of cfM with no specific assumptions 
regarding their spatial or spectral composition. We apply this data-
driven method to EEG recordings acquired from a large, hetero-
geneous group of participants and explore (1) cfM components 
identified with ICA and their variation over task conditions, (2) 
differences in cfM strength between healthy controls and schizo-
phrenia patients, and (3) possible genetic contributions to cfM. 
Our analyses identify plausible components of cfM, some of which 
are different between subject groups, and implicate genes involved 
in dopaminergic and GABAergic transmission as contributors to 
cfM. Overall, these findings suggest great promise for this approach 
in advancing the investigation of oscillatory interactions in health 
and disease.
MaterIals and Methods
PartIcIPants
The current work combines existing data from several related stud-
ies performed at the Olin Neuropsychiatry Research Center. We 
consider data from 189 participants, including 47 schizophrenia 
patients (SZ), 130 healthy controls (HC) and 12 subjects who were 
unaffected first-degree relatives of individuals with schizophrenia 
(REL). Subjects were recruited by newspaper, word of mouth, and 
outpatient units at the Institute of Living in Hartford, CT, USA. 
First-degree relatives were specifically recruited as part of a large-
scale study looking at probands and their unaffected relatives. 
Healthy controls were free from any history of DSM IV Axis-I diag-
nosis, as assessed with the structured clinical interview for DSM 
IV axis-I disorders (SCID) and were also interviewed to determine 
that there was no history of psychosis in any first-degree relatives. 
Patients met DSM IV TR diagnostic criteria for schizophrenia on 
the basis of the SCID. SCID diagnoses were made first by the clini-
cian performing the interview, which is videotaped, and second 
by an independent clinician who rated the videotape. If diagnoses 
disagreed, a consensus meeting was called to review all available 
information including the patient’s case file. All participants were 
substance-abuse free as assessed by urine toxicology and provided 
written, IRB-approved consent by Hartford Hospital.
To include as many datasets as possible in our study, we decided 
to use all participants instead of the relatively balanced subset, 
while assessing the effect of age, gender, and other factors on our 
measurements. Subject demographics are displayed in Table 1. 
Table 1 | Demographic, clinical, and behavioral data for subject groups.
  HC  SZ  REL  Test statistic  P value  HC vs SZ  P value
Number of subjects  130  47  12
Race (% Caucasian)  70.2  70.2  41.7  χ2
4, 171 = 3.41  0.49
Gender (% female)  52.3  38.3  50  χ2
2, 189 = 2.72  0.26
Handedness (% RH)  82.3  72.3  66.7  χ2
2, 170 = 1.95  0.38
Age* 26.0  ± 11.7  37.6 ± 11.6  36.5 ± 13.0  F2, 186 = 18.89  <10−7  t175 = 5.81  <10−7
fsIQa,b* 106.7  ± 7.7  101.0 ± 10.9        t64 = 2.48  0.02
PANSS (positive)c   16.2  ± 5.7
PANSS (negative)c   18.2  ± 6.5
PANSS (general)c   33.4  ± 11.7
N retained trials  391.4 ± 43.2  385.1 ± 54.7  402.1 ± 41.5  F2, 186 = 0.72  0.49
Mean RT (ms)b* 457.9  ± 85.4  527.8 ± 115.0  471.2 ± 82.3  F2, 186 = 9.67  <10−3  t175 = 4.36  <10−4
Percent detectedb* 95.8  ± 6.1  87.6 ± 18.8  97.9 ± 2.9  χ2
2, 186 = 4.48  0.11
Percent FAb,d* 0.31  ± 0.75  0.98 ± 1.37  0.11 ± 0.26  χ2
2, 186 = 15.98  <10−3  z = 3.64  <10−3
Data presented as mean ± SD or %. RH, right handed; PANSS, positive and negative symptom scale; RT, reaction time; FA, false alarms.
Asterisk denotes significant difference between groups.
aFull-scale IQ determined from National Adult Reading Test for 32 HC, 34 SZ, and 0 REL subjects.
bCorrected for age by linear regression.
cPANSS scores were recorded for 25 SZ subjects within 2 weeks of EEG collection.
dχ2 statistic determined from non-parametric Kruskal–Wallis test; z statistic approximated from Wilcoxon rank-sum test.
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triallelic system was genotyped as reported previously (Stein et al., 
2006). Samples analyzed with the taqman method were genotyped 
in duplicate for quality control; for gel-based genotyping, 8% of 
genotypes were repeated.
data analysIs
All analyses were conducted using MATLAB (MathWorks, Inc, 
Natick, MA, USA). Statistical comparisons were thresholded at 
P < 0.05 following Bonferroni correction for the number of com-
parisons within each analysis. Continuous EEG recordings were 
band-pass filtered from 1 to 200 Hz, and 60 Hz line noise was 
removed by subtracting the best-fit sine wave from the raw data 
in overlapping windows (http://chronux.org). Eye blink artifacts 
were removed using the ICA algorithm within in the EEGLAB 
toolbox as described previously (Delorme and Makeig, 2004; Liu 
et al., 2009a). EEG signals were segmented around the arrival of 
the tones, from 500-ms pre-stimulus to 1200-ms post-stimulus, 
and data epochs were baseline corrected. Only trials with correct 
responses (targets detected within 1000 ms; no false alarms) were 
included in the analysis. Data were excluded on the basis of noisy 
or dead channels (<1% occurrence), trial variance across time > 3 
mean ± SD, or voltage > 100 μV amplitude safeguard. On aver-
age, 20% of correct trials were rejected from each subject with no 
significant difference in the number of trials retained between 
groups (Table 1).
Cross-frequency modulation was quantified using the modula-
tion index, as described previously (Canolty et al., 2006; Cohen 
et al., 2009; see Figure 1A). Briefly, the preprocessed voltage trace 
from a single trial, x(t), was filtered into low-frequency (fP) and 
high-frequency (fA) bands, generating xfP(t) and xfA(t), respectively. 
Using the Hilbert transform, the analytic phase, φfP(t), and ampli-
tude envelope, AfA(t), were extracted from xfP(t) and xfA(t), respec-
tively, to form a composite signal z(t) = A(t)eiφ(t), which projects 
high-frequency power onto low-frequency phase. The raw modu-
lation index was then computed as the mean vector length of z(t), 
mz t raw =|( )|. Intuitively, coupling between low-frequency phase 
and high-frequency amplitude is present if the probability distri-
bution of z(t) is circularly non-uniform (see Figure 1A), equivalent 
to larger values of mraw. Because the vector length is dependent 
on signal amplitude, raw modulation indices were z-scored using 
the mean, μ, and standard deviation, σ, of 50 surrogate values: 
m = (mraw − μ)/σ, where surrogate values were generated under 
the null hypothesis of no modulation by randomly shuffling the 
amplitude time series to disrupt the phase–amplitude relationship 
(Cohen et al., 2009). Previous studies have used more surrogate 
values to generate the null distribution (e.g., 200 in Cohen et al., 
2009), however this was not possible in the current work given the 
computational time required to generate distributions for our large 
dataset. In preliminary testing, we confirmed that 50 surrogates 
yielded m values similar to and unbiased from those obtained with 
200. We further note that 50 surrogates is twice the number sug-
gested by Tukey’s rule of thumb for estimating moments of a dis-
tribution, which recommends that calculation of the kth moment 
is based on at least 5k observations (Sachs, 1992). Because cfM 
metrics can be affected by sharp edges in time series data (Kramer 
et al., 2008), we examined high-frequency  peak-locked averages of 
Control and patient groups showed no statistical differences on 
race, sex or handedness, but did show a significant age difference 
(HC: 26.0 ± 11.7, SZ: 37.6 ± 11.6; REL: 36.5 ± 13.0, F2, 186 = 18.89, 
P < 10−7). Therefore, age was regressed from all performance meas-
ures (i.e., IQ scores, reaction times, etc.) before comparing groups. 
IQ scores, estimated from the national adult reading test (NART) 
were available for 32 HC and 34 SZ. Positive and negative syndrome 
scale (PANSS) scores were available for 35 patients, however we 
restricted our analysis to symptom scores obtained within 2 weeks 
of EEG data acquisition (25 patients).
Of 47 schizophrenia patients, 35 were taking antipsychotic 
medication at the time of assessment; 6 took one or more typical 
antipsychotics, 24 took one or more atypical antipsychotics, and 
5 patients took a combination. In addition, 14 patients took one 
or more anti-depressant medications (including both SSRI and 
non-SSRIs), 4 patients were prescribed anti-anxiety medication, 
and 4 patients were taking both anti-depressant and anti-anxiety 
medications. Based on the available PANSS scores, we found no 
difference in symptom severity for patients taking (19/25) and not 
taking (6/25) antipsychotics (positive scores, SZ with medication: 
16.5 ± 4.5; without medication: 15.3 ± 9.1, t23 = 0.41, P =  0.68, 
Ppermute = 0.69; negative scores, SZ with medication: 19.2 ± 7.0; with-
out medication: 15.2 ± 2.7, t23 =  1.35, P =  0.19, Ppermute =  0.19; gen-
eral scores, SZ with medication: 33.9 ± 11.2; without medication: 
31.6 ± 14.0, t23 = 0.41, P =  0.68, Ppermute = 0.68; two-tailed t-test and 
permutation test with n = 10,000 permutations).
audItory oddball dIscrIMInatIon task
Subjects were presented with a series of standard tones (500 Hz), 
target tones (1000 Hz) and novel stimuli (e.g., tone sweeps, whis-
tles). Stimuli were 200 ms in duration with an inter-stimulus 
  interval varying between 1000 and 2000 ms. Standard tones 
occurred with a probability of 0.80 and target and novel stimuli 
each occurred with a probability of 0.10. Subjects were asked to 
respond as quickly and accurately as possible with their right index 
finger to target stimuli and to ignore standard and novel stimuli. 
The task was performed in two 8-min runs, with approximately 
250 stimuli per run. Age-corrected performance measures are 
provided in Table 1.
eeG acquIsItIon
Multi-channel EEG data were acquired using a Bioelectric Amplifier 
System (SA Instrumentation Co., San Diego, CA, USA). Scalp 
potentials were recorded at 62 electrode sites in accordance with the 
International 10–20 System. Electrooculogram data were recorded 
from electrodes located on the lateral and supra-orbital ridges of 
the right eye. All electrodes were referenced to the nose. Electrical 
impedances were maintained below 10 kΩ. EEG signals were ampli-
fied (20,000 gain) and digitized at 500 Hz.
GenotyPInG
Genotype data at 26 polymorphic loci putatively involved 
with schizophrenia were available for 170 of 189 participants. 
Polymorphisms, detailed in Table 2, were defined previously as part 
of several ongoing studies investigating the genetic basis of schizo-
phrenia. Genotyping was performed at Yale using a fluorogenic 
5′ nuclease assay or, for VNTR polymorphisms, by PCR ampli-
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we found little evidence for spurious coupling. We also examined 
spectrograms of trough-locked data segments and found clear 
modulation of high-frequency power by low-frequency phase (see 
Figure 3).
For each trial of EEG data, cfM was calculated between six low-
frequency phase bands (fP = 1–24 Hz, width = 4 Hz) and 15 high-
frequency amplitude bands (fA = 30–200 Hz, width = 11.3 Hz) to 
generate a comodulogram (e.g., Figure 1B). This procedure was 
performed at 62 scalp channels and comodulograms were averaged 
over trials within each condition (target, novel or standard stimuli), 
creating a data set of 90 modulation indices × 62 locations × 3 
conditions for each subject.
We used ICA to decompose patterns of cfM from the large 
set of comodulograms (Hyvärinen et al., 2001). To apply ICA 
to the modulation data, comodulograms were flattened into 
row vectors and the means were subtracted. Because modula-
tion indices have been z-scored to form appropriate metrics 
of coupling (see above), no further amplitude standardization 
between frequencies, channels, or subjects is necessary. Rows 
were then vertically concatenated over conditions and subjects 
to form the data matrix (XM). The number of components in 
XM was estimated following the method of Liu et al. (Liu et al., 
2009a): we used the Akaike information criterion (AIC) as an 
upper bound of dimensionality since it tends to overestimate 
component number (De Ridder et al., 2005) and reduced the 
number of components until they were stable between 500 
bootstrap subject resamplings. AIC estimated the number of 
components at 9, which we reduced to 6 based using a stopping 
criterion of cluster quality index of greater than 0.8 for all com-
ponents (Himberg et al., 2004). ICA was performed using the 
Infomax algorithm (Bell and Sejnowski, 1995), which linearly 
decomposed XM into six sources (rows of SM) after PCA com-
pression, and their associated loading parameters (columns of 
AM). From the full decomposition, we observed that modulation 
loading parameters showed association with subject age (ICM 1: 
r = −0.19, P < 0.01; ICM 4: r = 0.27, P < 0.001; ICM 5: r = −0.13, 
P = 0.07) or sex (ICM 1: t187 = 2.04, P = 0.04; ICM 2: t187 = 2.99, 
Table 2 | Genotyped polymorphic loci.
Accession  Locus Nearest  Description  Alleles  Position/  PHWE  MAF Pa 
numbera   gene      effect
            SZ HC SZ HC
rs1655285  1q42  TSNAX  Translin-associated factor X  C/G  Intronic  1.00  1.00  0.15  0.12  0.57
rs751229  1q42  DISC1  Disrupted in schizophrenia 1  C/T  Intronic  0.40  1.00  0.37  0.38  0.39
rs3738401  1q42  DISC1   Disrupted in schizophrenia 1  G/A  264Arg → Gln  0.13  0.14  0.28  0.24  0.15
rs821616  1q42  DISC1   Disrupted in schizophrenia 1  T/A  704Ser → Cys  1.00  0.38  0.13  0.24  0.40
rs1411771  1q42  DISC1  Disrupted in schizophrenia 1  C/T  3′  UTR  1.00 0.77 0.35 0.24  0.39
rs980989  1q42  DISC1   Disrupted in schizophrenia 1  G/T  3′  UTR  0.10 0.75 0.24 0.21  0.32
rs279869  4p12  GABRA2   GABA A receptor, α2  A/C  Intronic  0.70 0.65 0.48 0.39  0.43
rs279858  4p12  GABRA2  GABA A receptor, α2  A/G 132Lys  → Lys  0.66  1.00  0.43  0.41  0.92
rs279837   4p12  GABRA2   GABA A receptor, α2  G/A  Intronic  0.69 0.83 0.44 0.45  0.86
rs567926  4p12  GABRA2   GABA A receptor, α2  C/T 3′ flanking  1.00  1.00  0.50  0.37  0.80
rs28363170  5p15  SLC6A3   Dopamine transporter 1  VNTR  3′ UTR, 40 bp  0.02  1.00  0.29  0.28  0.11
rs1049353  6q14  CNR1   Cannabinoid receptor 1   G/A  453Thr →  Thr  0.29 0.53 0.21 0.21  0.90
BV677278b  6p22  DCDC2  Doublecortin domain containing 2  −/+  STR  Intronic  1.00 0.33 0.08 0.12  0.84
rs11238214  7p12  DDC   Dopa decarboxylase   G/A  5′  flanking  0.66 0.08 0.35 0.40  0.45
rs1611115  9q34  DBH   Dopamine beta-hydroxylase  C/T  5′ flanking  0.48  0.75  0.16  0.21  0.52
rs1805186   11p15  DRD4   Dopamine receptor D4  VNTR  exon 3, 48 bp  1.00  1.00  0.34  0.18  0.01
rs6265  11p13  BDNF  Brain-derived neurotrophic factor  G/A  66Val → Met  1.00  1.00  0.21  0.21  0.95
rs6277   11q23  DRD2   Dopamine receptor D2  C/T  319Pro →  Pro  0.10 0.41 0.35 0.25  0.81
rs1799732  11q23  DRD2  Dopamine receptor D2  −/C 5′ near  1.00  1.00  0.06  0.09  0.96
rs868437  15q14  CHRNA7  Nicotinic cholinergic receptor, α7 C/T  Intronic  1.00 0.59 0.35 0.28  0.67
rs2337506  15q14  CHRNA7   Nicotinic cholinergic receptor, α7  A/G  Intronic  1.00  0.76  0.23  0.22 0.79
rs16969968  15q24  CHRNA5  Nicotinic cholinergic receptor, α5 G/A  398Asp  →  Asn  0.67 0.45 0.33 0.31  0.54
rs28386840  16q12  SLC6A2  Noradrenaline transporter  A/T  5′  flanking  1.00 0.77 0.31 0.24  0.41
rs25531  17q11  SLC6A4   Serotonin transporter  A/G  5′  near  1.00 0.68 0.40 0.46  0.55
rs4795541  17q11  SLC6A4  Serotonin transporter  LA/LG/Sc 5′  near  1.00 0.06 0.42 0.49  0.78
rs4680  22q11 COMT  Catechol-O-methyltransferase  G/A  158Val  →  Met 0.45 0.68 0.44 0.48  0.33
PHWE, P-value for deviation from Hardy–Weinberg equilibrium (Fisher’s exact test); MAF , minor allele frequency; Pa, P-value for association between genotype and 
diagnosis (χ2 test); VNTR, variable number tandem repeat; −, deletion; +, insertion; STR, short tandem repeat.
aAccession numbers for dbSNP unless otherwise noted.
bGenBank accession number.
cTri-allelic locus with long variants (LA and LG) and short variant (S).
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coded as −1, 0, or 1, corresponding to minor homozygous, het-
erozygous, and major homozygous. At loci with more than two 
alleles (SLC6A3 VNTR, DRD4 exon 3 VNTR, and SLC6A4 pro-
moter region LA/LG/S) we initially sorted genotypes in order of 
possible functional effects (Asghari et al., 1995; Fuke et al., 2001; 
Hu et al., 2006). For comparison, we also re-classified genotypes to 
conform to a biallelic ([A|B]) system (SLC6A3: [≥10|≤9 repeats]; 
DRD4: [≥7|≤6 repeats]; SLC6A4: [LA|LG or S]) and found no dif-
ference in the results. Thus we retained biallelic classification at 
all loci for simplicity.
Before performing ICA on the genetic data, we imputed missing 
values (<5% of all genotypes). For loci in linkage disequilibrium 
(LD; r2 > 0.8), we used linked polymorphisms as a reference. For 
remaining loci, missing values were imputed using the genotype 
from the individual with the most similar set of genetic data. We 
compared this method with filling missing values with the most 
common, least common, or a randomly assigned genotype. None 
of these methods produced significantly different results in the 
sources identified by ICA, signifying little impact of imputation. 
For direct associations of genotypes with ICM loading parameters 
(Figures 6C–F) we used raw (un-imputed) data, thus the number 
genotyped individuals varies slightly between polymorphisms.
Following imputation, subject rows of genetic data were con-
catenated and the means were removed to form XG. AIC estimated 
25 genetic sources, which we reduced to 16 based on stability in 
n = 1000 bootstrap resamplings (Liu et al., 2009a,b). Relative con-
tributions of polymorphisms to components were determined 
from the variability between bootstrap resamplings. Homologous 
P = 0.05). As a conservative correction, we linearly regressed 
these factors from the columns of AM before proceeding with 
statistical comparisons between groups or across genotypes.
Along with the bootstrap subject resamplings, we ensured that 
the sources were representative of features present in all subjects 
and trials by visually comparing (1) separate decompositions of HC 
and SZ groups, (2) separate decompositions using only target, novel 
or standard conditions, and (3) decompositions using randomly 
selected trials to match the number of trials across all subjects. In 
all cases, the identified sources were similar to those found from 
the full data set. 
Trough-locked spectrograms of gamma power (see Figure 3) 
were computed as outlined in (Canolty et al., 2006). From data at 
electrodes FZ and OZ, we identified theta (4–8 Hz) or beta (12–
16 Hz) troughs as local minima in the filtered phase time series, 
then extracted the raw data centered on each trough in 600 ms 
(beta) or 1200 ms (theta) windows. Normalized gamma power time 
series of these data segments were then calculated by (1) band-pass 
filtering the extracted signal into 30 linearly spaced bands between 
30 and 200 Hz (narrower bands than used to generate the comodu-
lograms), (2) z-scoring each band-passed signal, (3) applying the 
Hilbert transform to obtain the amplitude time series of each band, 
and (4) point-wise squaring the amplitude time series to obtain the 
power time series. Spectrograms of the normalized gamma power 
show the average over data segments from all trials and conditions. 
The number of segments included for single subjects were 2,442 
(beta-locked, Figure 3A, left) and 1,274 (theta-locked, Figure 3B, 
left); the number of segments for the group average were 449,631 
(Figure 3A, right) and 221,697 (Figure 3B, right).
FiGuRE 1 | Schematic of cross-frequency modulation analysis. (A) Steps to 
compute the cfM index (m). AOD trials are pre-processed and filtered into 
low-frequency bands [e.g., fP = 12–16 Hz, forming xfP(t)] and high-frequency bands 
[e.g., fA = 110–120 Hz, forming xfA(t)]. Analytic phase, φ(t), and amplitude envelope, 
A(t), are extracted from xfP(t) and xfA(t), respectively, to form a composite signal: 
z(t) = A(t)eiφ(t). Coupling between low-frequency phase and high-frequency amplitude 
is present if the probability distribution of z(t) is circularly non-uniform, equivalently, if 
the length of z(t), mz t raw = |( )|, is different from zero. Raw modulation indices are 
transformed into z-scores based on a null distribution from surrogate datasets. 
(B) Steps in (A) are repeated for all fP and fA combinations to produce the 
comodulogram. This is repeated over trials, conditions (target, novel or standard 
stimuli), EEG channels, and subjects to generate the full dataset. (C) For each 
subject, comodulograms are averaged over trials and data from all channels are 
concatenated to form a single row for each condition. Vertical concatenation of these 
rows forms the data matrix (XM). ICA estimates a mixing matrix (AM) and set of 
independent components (SM) from XM. The columns of AM indicate the loading 
parameters or weights of a particular component for each subject and condition. The 
rows of SM correspond to the component topography and spectral composition.
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3 conditions (target, novel and standard stimuli) from the 189 
subjects were decomposed into six independent sources using 
ICA (Hyvärinen et al., 2001;  Figure 1C). Applied here, ICA 
decomposes the comodulograms into linear factors based on 
the covariation of cfM patterns across subjects and the maximal 
independence of factors over spatial topography (EEG channels) 
and frequency composition (profile over fP and fA). This approach 
allows for different patterns of cfM to have overlapping topogra-
phies and makes no specific assumptions regarding the frequency 
composition of each factor.
cross-frequency ModulatIon coMPonents
Six cfM components (ICM) accounting for 96.1% of the data 
variance are shown in Figure 2. Each ICM has a scalp topogra-
phy (Figure 2A), identified from the frequency bin with greatest 
modulation amplitude, and a comodulogram (Figure 2B) which is 
displayed for a representative channel. Across channels, comodu-
lograms are quite consistent, with differences largely captured by 
changes in scale. To aid interpretation, the ICM are scaled to the 
original data units (z-scores) using multiple regression. As indicated 
by the color bars adjacent to each panel in Figure 2, the magnitudes 
of cfM vary greatly between components, with ICM 1 capturing 
the large majority of cfM variance. Because ICM 1 exhibits such 
  components between runs were identified using the minimum 
distance (d) between components, where d = 1−|rij|, and rij is the 
correlation coefficient between component SM(i) and bootstrapped 
component S ˆ
M(j) (Himberg et al., 2004).
results
We examined patterns of phase-to-amplitude cfM in EEG data 
recorded from 47 schizophrenia patients (SZ) and 130 healthy con-
trols (HC), and 12 participants who were unaffected first-degree 
relatives of individuals with schizophrenia (REL) during perfor-
mance of an auditory oddball paradigm. This paradigm asks sub-
jects to detect and respond to rare target tones presented in a series 
of frequent standard tones and infrequent novel sounds, and has 
been repeatedly demonstrated to evoke differential scalp potentials 
in HC and SZ (Braff et al., 2007; Allen et al., 2009). Table 1 provides 
demographic and task performance data.
Cross-frequency modulation was quantified using a modula-
tion index based on the distribution of high-frequency ampli-
tude as a function of low-frequency phase (Canolty et al., 2006; 
Figure 1A). Modulation indices were calculated between pairs 
of low-frequency phase bands (fP = 1–24 Hz, 6 bands) and high- 
frequency amplitude bands (fA = 30–200 Hz, 15 bands). The 
pattern of cfM is displayed in a comodulogram, with phase fre-
quency (fP) along the abscissa and amplitude frequency (fA) on 
FiGuRE 2 | Cross-frequency modulation components. Component scalp 
topographies (A), spectral comodulograms (B), and loading parameters (C). 
The scalp distribution of each component is identified using the amplitude of 
the modulation index from the frequency bin with the greatest average 
amplitude over channels. Comodulograms in (B) are displayed for a single 
representative channel, indicated by the white dots in (A). As indicated by the 
color scales adjacent to each panel, the magnitudes of cfM vary greatly 
between components; components are listed in decreasing order of their 
variance. (C) Component loading parameters for each condition stratified by 
SZ (red) and HC (blue) groups (REL subjects not shown). Error bars in this and 
all subsequent plots denote ± 1 SEM. T* and G* indicate significant 
differences over conditions or groups, respectively, as determined with a 
repeated measures one-way ANOVA (P < 0.05, Bonferroni corrected for 6 
tests).
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ICM 1 were significantly different between HC and REL (t140 = 2.27, 
P < 0.05) and showed a trend for ICM 4 (t140 = 1.68, P = 0.10). 
Loading parameters of components 1 and 4 were also significantly 
negatively correlated (r = −0.56, P < 10−15, Figure 4C), and this 
relationship was particularly strong for schizophrenia patients (HC: 
r = −0.37, P < 0.0001; SZ: r = −0.64, P < 0.00001; REL: r = −0.68, 
P < 0.05). These findings suggest that subjects with less global cfM 
(ICM 1), have altered modulation in fronto-temporal regions (ICM 
4), and that this differential pattern of modulation is most pro-
nounced in SZ patients.
Given the group difference, we then examined whether cfM 
patterns covaried with symptoms in SZ. We found no relation-
ships between PANSS scores and loading parameters of compo-
nents 1 or 4, but found a significant correlation between negative 
symptom scores and the weights of ICM 6 after correcting for 18 
tests (r = −0.69, P < 0.005, Figures 5A,B). This indicates that more 
severe negative symptoms are associated with less cfM between 
low-frequency phase and high-gamma power.
The ANOVAs also identified significant differences over the 
target, novel and standard conditions for ICM 1, ICM 2, and ICM 5 
(F2,175 = 10.3, P < 0.00005; F2,175 = 5.23, P < 0.01; and F2,175 = 6.73, 
P  < 0.005, respectively; Bonferroni corrected for 6 tests; see 
Figure 2C). For ICM 5, subject weights increased with the sali-
ence or significance of the tone (target > novel > standard). This 
trend was reversed for ICM 1 and ICM 2, which showed the least 
activation during target trials. Note that we found no relation-
ship between ICM weights and various measures of task perfor-
mance (mean reaction time, percent correct responses and percent 
false alarms; P > 0.05 for all tests), thus it is unlikely that any of 
the components represent neuronal activity directly underlying 
target detection. Rather, trends likely reflect general changes in 
the patterns of activity that accompany different conditions. An 
increase in delta phase modulation (ICM 5) may reflect sensory 
selection (Lakatos et al., 2008; Monto et al., 2008; Händel and 
Haarmeier, 2009), or enhanced coordination between auditory 
and motor systems in preparation for a response. The cfM in 
theta and other bands (ICM 2 and ICM 1) may indicate ongoing 
internal processes that are disrupted or dampened by the arrival 
of attention-demanding stimuli.
GenetIc assocIatIons
Having identified schizophrenia-relevant components of cfM, 
we explored whether these were associated with genetic factors. 
Genotypes from 26 polymorphic loci in putative SZ risk genes 
were available for 170/189 subjects (36/47 SZ and 134/142 HC, 
including 9/12 REL). Genetic data included single nucleotide poly-
morphisms (SNPs) and variable number tandem repeats (VNTRs) 
from 16 different genes (see Table 2). Several of the polymorphisms 
were in close physical proximity and showed some degree of LD 
(Figure A1 in Appendix). To avoid redundant tests for association 
with cfM components, we again employed ICA to identify inde-
pendent genetic factors (Liu et al., 2009a).
Independent component analysis decomposed the genetic data 
into 16 components, capturing 94.9% of the original variance. We 
evaluated associations between cfM and genetic components (ICG) 
by performing linear regression between the loading parameters of 
  widespread spatial and spectral activation, other components can 
be considered as representing more localized addition or subtrac-
tion of modulation in particular frequency bands.
Several features are apparent in the spatial and spectral pat-
terns of cfM components. First, some components exhibit great 
specificity. For example, ICM 2 shows significant modulation 
almost exclusively between theta phase (fP = 4–8 Hz) and gamma 
amplitude (fA = 30–200 Hz), spatially localized to posterior/occip-
ital electrodes. ICM 5 shows a similar pattern, with delta phase 
(fP = 1–4 Hz) modulating the amplitudes of high-frequency oscil-
lations (fA = 30–120 Hz) over central/posterior electrodes. A second 
notable feature is a general antagonism/opposition between cfM at 
lower and higher phase frequencies. For example, ICM 3, which is 
localized to fronto-temporal electrodes, shows mild positive modu-
lation between phases at fP ≤ 8 Hz and gamma amplitude, with 
simultaneous negative modulation between phases at fP ≥ 12 Hz 
and high-frequency amplitude. ICM 4, which also peaks at fronto-
temporal electrodes but extends through central and more posterior 
electrodes, shows a similar pattern, though with opposite polarity. 
Third, there is a diagonal trend across the comodulograms, most 
apparent in ICM 1. Although ICM 1 exhibits nearly global activation, 
modulation is notably absent or slightly negative below a diagonal 
representing roughly fA/fP ≤ 4 (i.e., right, lower corner). The diagonal 
trend, which is also seen in ICM 3, ICM 4, and the comodulogram 
grand average (Figure 1B), is consistent with a theorized optimal 
relationship between the phase and amplitude bands for cfM to 
occur (Roopun et al., 2008).
To ensure that our ICA approach accurately captured cfM pat-
terns, we examined fluctuations in gamma power at individual 
channels, shown in Figure 3 (see Materials and Methods). We veri-
fied robust oscillations in FZ gamma power locked to beta phase 
(fP = 12–16 Hz, Figure 3A), as well as OZ gamma power modulated 
by theta phase (fP = 4–8 Hz, Figure 3B), validating patterns of cfM 
reflected in components ICM 1 and ICM 2, respectively. We also 
ensured that the cfM components represented features found in 
all subjects by performing separate ICA decompositions on the 
HC and SZ groups separately. All six components were present in 
the separate decompositions (not shown), though were notice-
ably noisier for the SZ group which is expected given the smaller 
sample size.
We next examined condition-specific loading parameters, which 
indicate the contribution of each component to the modulation 
data for an individual subject. Component loading parameters 
for HC and SZ, corrected for age and sex via regression, are dis-
played in Figure 2C. Weights between conditions were highly 
correlated within subjects (Figures 4A,B), thus we evaluated dif-
ferences between groups and conditions with a repeated measures 
ANOVA. After Bonferroni correcting for tests over 6 components, 
the ANOVAs indicated significant group differences for the load-
ing parameters of ICM 1 and ICM 4 (F1,175 = 9.25, P < 0.005 and 
F1,175 = 17.5, P < 0.0001, respectively). These differences were in 
opposite directions: ICM 1 weights were larger in HC, while ICM 
4 weights were larger in SZ. Though not included in the ANOVA, 
we observed that the loading parameters of the REL subjects were 
more similar to those of SZ for ICM 1 (mean ± SD; HC: 0.48 ± 0.03; 
SZ: 0.45 ± 0.05; REL: 0.45 ± 0.05), and were intermediate for ICM 
4 (REL: 0.08 ± 0.05; SZ: 0.12 ± 0.08; REL: 0.10 ± 0.09). Despite the 
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stratification. We also verified that the loading parameters ICG 4 and 
ICG 6 showed no significant association with age or sex (P ≥ 0.10 
for all comparisons).
Examining the genetic components, ICG 6 showed a large con-
tribution from rs6277 (see Figure 6B, top), a polymorphism within 
the gene for the dopamine D2 receptor (DRD2), and a smaller con-
tribution from rs1799732, located in the promoter region of DRD2. 
ICG 4 (Figure 6B, bottom) showed contributions from rs279869, 
rs279858, rs279837, and rs567926, all found within or flanking 
the gene for the α2-subunit of the GABAA receptor (GABRA2). 
Using bootstrap resamplings to assess the component stability 
(n = 1000) we found that for ICG 6, only SNP rs6277 contrib-
uted a weight significantly different from zero (P < 0.05, corrected 
ICM 1 and ICM 4 and the loading parameters of the ICGs, with subject 
diagnosis and genetic × diagnosis interaction terms included in 
the regression models (Begleiter and Porjesz, 2006). Associations 
between (1) ICM 1 and ICG 6 (Figure 6A, top; F3,166 = 6.25, P < 0.0005), 
(2) ICM 4 and ICG 6 (Figure 6A, bottom; F3,166 = 8.50, P < 0.00005), 
and (3) ICM 4 and ICG 4 (Figure 6A, bottom; F3,166 = 7.65, P < 0.0001) 
were significant at P < 0.05 after correction for 32 tests. Examination 
of the individual beta weights revealed a main effect of genetic 
component 6 on ICM 1 (i.e., independent of diagnosis; Figure 6A, 
top; t166 = 2.92, P < 0.005). Associations with ICM 4 were both due 
to interactions between the genetic components and the diagnosis 
(Figure 6A, bottom; t166 = 3.59, P < 0.0005 and t166 = 3.35, P < 0.005 
for ICG 6 and ICG 4, respectively). Including subject race in the 
regression model yielded nearly identical results (Figure A2A in 
FiGuRE 3 | Examples of phase-to-amplitude modulation. (A,B) 
Spectrograms of mean normalized gamma power, time-locked to the beta 
[fP = 12–16 Hz, (A)] or theta [fP = 4–8 Hz, (B)] trough for a single subject (top left) 
and all subjects (top right). Spectrograms include data segments from all trials 
and conditions. Gamma power is normalized within narrow bands (∼6 Hz) to 
permit comparison across frequencies. (bottom) Plot of the averaged beta (A) or 
theta (B) trough-locked signal (black) and normalized gamma power, averaged 
over frequency (fA = 30–200 Hz, gray). Examples of beta modulation (A) are 
recorded from frontal electrode FZ (see Figure 2A), while examples of theta 
modulation (B) are from posterior electrode OZ.
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rs567926, all in relatively high LD with one another (r2 > 0.5, see 
Figure A1), contributed significant weights.
Given that the genetic components were largely composed of 
single (or a few linked) polymorphisms, we performed post hoc 
association tests between cfM components and individual SNPs. 
Shown in Figure 6C, the DRD2 rs6277 genotype was   significantly 
correlated with the loading parameters of ICM 1 (r  =  −0.20, 
P < 0.01). As expected from the regression model, this trend was 
present within both HC and SZ groups (r = −0.20, P < 0.05 and 
r = −0.30, P = 0.08, respectively), with copies of the C allele associ-
ated with weaker cfM. For ICM 4, the regression model indicated 
an interaction between genetic components and diagnosis, thus 
we examined the effect of DRD2 rs6277 genotype while stratifying 
by group (Figure 6D). We found a strong association for the SZ 
subjects, (r = 0.64, P < 0.00005) and no trend for the HC group 
(r = 0.02, P = 0.82). We confirmed that these relationships were not 
due to heterogeneous population structure, as correlations persisted 
in the subset of subjects identifying as Caucasian (ICM 1, all subjects, 
n = 115: r = −0.24, P < 0.05; ICM 4, SZ, n = 26: r = 0.61, P < 0.001). 
We additionally verified that DRD2 rs6277 genotypes were not 
significantly different across subject age (r = 0.01, P = 0.87), sex or 
(χ2
2,166 = 1.79, P = 0.40).
Relationships between the loading parameters of ICM 4 and 
GABRA2 genotypes also varied as a function of diagnosis. SZ 
exhibited a significant correlation with GABRA2 rs279869 geno-
type (Figure 6E; r = 0.42, P < 0.05), which we verified within the 
Caucasian subset (r = 0.48, P < 0.05). In contrast, HC showed no 
association between rs279869 genotype and ICM 4 loading param-
eters (r = −0.07, P = 0.46). Similar trends were observed for the addi-
tional three GABRA2-associated polymorphisms (Figure A2B in 
Appendix). As with DRD2 rs6277, GABRA2 genotypes showed no 
statistical distinction across age (e.g., GABRA2 rs279869: r = −0.06, 
P = 0.45), or sex (e.g., GABRA2 rs279869: χ2
2,162 = 3.50, P = 0.17; 
with similar findings for rs279858, rs279837 and rs567926). To 
putatively combine information over the different loci, we com-
puted the number of risk alleles from the four GABRA2 SNPs. 
The risk allele was determined as the allele with the quantitative 
trait furthest from the HC group (e.g., allele A in Figure 6E). We 
found a significant positive correlation between the number of 
risk alleles in SZ and the magnitude of modulation component 4 
(Figure 6F, r = 0.45, P < 0.01), indicating a roughly additive effect 
of the individual GABRA2 polymorphisms. No such relationship 
was found for the HC group (r = −0.01, P = 0.91), suggesting that 
these GABRA2 genotypes interact with other factors (genetic or 
environmental) specific to the schizophrenia background.
dIscussIon
In this study, we have used data-driven methods to examine pat-
terns of cfM in a large (n = 189), heterogeneous group of subjects. 
This approach has yielded three main contributions: (1) the iden-
tification of spatially distinct and concurrent interactions between 
low-frequency phase and high-frequency power, (2) the demon-
stration of robust differences in cfM patterns between controls and 
schizophrenia patients, and (3) the demonstration of associations 
between cfM and genetic polymorphisms. We discuss the signifi-
cance of each of these findings and their limitations in turn.
FiGuRE 5 | Relationship between cross-frequency modulation and 
patient symptoms. (A) Plot of correlation coefficients between ICM 
loading parameters (averaged over condition) and positive (red), negative 
(blue), and general (black) symptom scores. Only patients with PANSS 
scores collected within 2 weeks EEG acquisition were included in this 
analysis (n = 25). Error bars ( ± 1 SEM) estimated with 1000 bootstrap 
resamplings. A single significant correlation (indicated by the asterisk, after 
Bonferroni correction for 18 tests) was found between negative symptoms 
and ICM 6 (r = −0.69, P < 0.005). (B) Scatter plot of negative symptom 
scores and the loading parameters of ICM 6. Dashed black line represents 
the least-squares linear fit.
FiGuRE 4 | Relationships between cross-frequency modulation 
loading parameters. (A) Full correlation matrix between loading 
parameters (AM) for each cfM component and each condition (target, novel 
and standard stimuli). In general, component weights are well correlated 
between conditions (values along the diagonal). (B) Example of correlation 
between loading parameters of target tones and standard tones for ICM 1. 
Solid gray line indicates unity. (C) Negative correlation between the loading 
parameters of ICM 1 and ICM 4. Here, the loading parameters have been 
averaged over condition. Dashed black line shows the least-squares linear 
fit to the data.
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of the negative natural logarithm of the P-values for the regression models 
between each of the 16 genetic components and cfM components 1 (top) and 
4 (bottom). Pink shaded region indicates the P-values for the regression model; 
black and white regions show the P-values for the genetic and 
genetic × diagnosis terms, respectively. Asterisks denote significant models at 
P < 0.05 after Bonferroni correction for 32 tests. (B) Genetic component 6 (top) 
and component 4 (bottom). Contributions of individual polymorphisms are 
z-scored to facilitate interpretation. Error bars were determined with 1000 
bootstrap resamplings. Asterisks denote polymorphisms contributing weights 
significantly different from zero (P < 0.05, corrected for 26 tests). (C–F) Plots of 
modulation component loading parameters as a function of genotype. In (D) 
and (E), data is stratified by SZ (red) and HC (blue) to highlight group × diagnosis 
interactions. In (F), the number of risk alleles is determined from the genotypes 
of rs279869, rs279858, rs279837 , and rs567926; for clarity, only the SZ group 
data is shown. Dashed line shows the least-squares linear fit to the data. The 
number of individuals with each genotype is indicated adjacent to the data 
marker.
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(ICM 1, ICM 2) as the tone saliency and behavioral relevance 
increased. Further support comes from recent work by Voytek 
and colleagues, who demonstrate localized differences in the rela-
tive strength of theta-to-gamma coupling and alpha-to-gamma 
coupling as a function of task demands (Voytek et al., 2010), 
putatively reflecting dynamic alterations in functional connectiv-
ity and regional engagement.
While ICA affords advantages in terms of analytic feasibility 
and scope, it is important to mention the interpretive challenges 
of such an approach. Because components have no inherent mean-
ing ascribed to them beyond statistical independence, researchers 
must make their own interpretations of topographic and frequency 
patterns. Importantly, researches must view the components as a 
whole, keeping in mind that they simply represent a linear decom-
position of the data. As an example, consider the pattern of cfM 
represented by ICM 4. One notices subtle “gaps” and “bumps” in 
the modulation indices around fA = 140 Hz and fA = 170 Hz. These 
“gaps” are puzzling: it is commonly believed that high-gamma 
power (e.g., fA > 80 Hz) represents a single localized broadband 
signal that should be uniformly modulated by low-frequency phase 
(He et al., 2010; Miller et al., 2010), thus one expects a somewhat 
continuous pattern of cfM extending over the high-gamma range 
(e.g., see Figure 3). However, we note that ICM 1 shows the inverse 
pattern of “gaps,” i.e., greater modulation in frequency bands that 
are reduced for ICM 4. Because these components share some similar 
spatial and spectral features (e.g., greater weights over fronto/tem-
poral electrodes) as well as covariance in loadings (see Figure 4A), 
the separation of these sources with ICA may be imperfect and 
result in a general “give and take” in modulation values between the 
components. The discontinuous pattern of cfM in ICM 4, and well 
as the cfM specific to very high frequencies (fA > 150 Hz) in ICM 6, 
may truly represent modulation within specific high-gamma sub-
bands, however they may also represent an incomplete “un-mixing” 
of sources particular to this dataset and decomposition. Only with 
replication in independent datasets can we assess the robustness 
and functional relevance (if any) of these components. We note 
that ICA has proven to be of great value for delineating meaningful 
EEG timeseries and imaging spatial maps (for review see Calhoun 
et al., 2009), however, as with any decomposition technique, there 
is no guarantee that identified components will have physiologi-
cal relevance or that they will represent specific neural processes.
Consistent with our predictions, patterns of cfM were signifi-
cantly altered in patients, who showed decreased global cfM (ICM 
1) and increased coupling at fronto-temporal electrodes (ICM 4). 
Intriguingly, the small number of unaffected SZ relatives (n = 12) 
exhibited intermediate magnitudes of ICM 1 and ICM 4. We specu-
late that specific cfM patterns could constitute an endophenotype 
or disease liability marker (Braff et al., 2007; Allen et al., 2009), as 
supported by our genetic association results (see below). While it is 
tempting to relate the altered cfM found in schizophrenia patients to 
the etiology of the disease, we feel that such inference is premature. 
Cross-frequency interactions were assessed while subjects engaged 
in a single behavioral paradigm known to evoke different event-
related responses between subject groups (Braff et al., 2007; Allen 
et al., 2009) and it is quite possible that the observed differences 
are related to the evoked potentials or task-specific behaviors. We 
Phase-to-amplitude coupling between low- and high-frequency 
signals has emerged as a fundamental and ubiquitous feature 
of neural oscillations. First described between the phase of the 
robust hippocampal theta rhythm and firing of individual place 
cells (O’Keefe and Recce, 1993), cfM has since been identified 
within numerous cortical and sub-cortical areas (Lakatos et al., 
2005; Mormann et al., 2005; Canolty et al., 2006; Demiralp et al., 
2007; Osipova et al., 2008; Cohen et al., 2009), as well as between 
distinct regions (Bruns and Eckhorn, 2004; de Lange et al., 2008; 
Sirota et al., 2008; Maris et al., 2011). The spectral characteristics of 
cross-frequency coupling have also been expanded: high-frequency 
amplitudes are modulated not only by the theta rhythm (Canolty 
et al., 2006) but also by oscillations in the delta (Lakatos et al., 2005; 
Monto et al., 2008; Händel and Haarmeier, 2009), alpha (Osipova 
et al., 2008; Cohen et al., 2009; Voytek et al., 2010), and beta bands 
(de Lange et al., 2008). Furthermore, there is evidence for a “nested 
hierarchy” of interacting oscillations (Lakatos et al., 2005, 2008; 
Monto et al., 2008).
Our examination of cfM used ICA to identify modulation fea-
tures at the group level. A principle advantage of this approach is 
the reduction of a large dataset that is both spatially and spectrally 
redundant into a manageable number of components well-suited 
for visual and statistical comparisons. We note that the combina-
torial nature of this dataset (i.e., 90 modulation indices × 62 loca-
tions × 3 conditions) would have prohibited effective comparisons 
of cfM between groups or task conditions without the benefit of 
dimension reduction/feature identification. Such approaches will 
become increasingly important as studies investigate “inter-areal” 
coupling between oscillations at different spatial locations (Bruns 
and Eckhorn, 2004; de Lange et al., 2008), as demonstrated recently 
by Maris et al. (2011). In an innovative and systematic investiga-
tion, Maris et al. (2011) computed phase-to-amplitude coupling 
between all pairs of channels and used tensor decomposition, a 
generalization of singular value decomposition for arrays with more 
than two dimensions, to identify sources of cfM and character-
ize the spatial and spectral properties of low-frequency coupling 
oscillations and the corresponding high-frequency phase-locked 
activity. While tensor decomposition makes assumptions regard-
ing the spatio-spectral separability of cfM components (i.e., that 
coupling can be fully described as the product of spatial maps and 
frequency profiles), such assumptions are quite plausible for phase-
amplitude coupling, and we expect that this and other decomposi-
tion methods will be used increasingly to describe and understand 
oscillatory interactions.
A second benefit of ICA is the discovery of multiple independ-
ent features of modulation, without any constraints regarding 
their spatial or spectral composition. In agreement with pre-
vious studies, we found evidence for the presence of specific 
theta-to-gamma (ICM 2; Canolty et al., 2006; Demiralp et al., 
2007) and delta-to-gamma coupling (ICM 5; Lakatos et al., 2005; 
Monto et al., 2008; Händel and Haarmeier, 2009). However, ICA 
additionally revealed the occurrence of numerous, simultaneous, 
cross-frequency interactions with specific spatial profiles (see 
Figure 2), suggesting a role for cfM in the concurrent coordina-
tion of multiple neural ensembles (Canolty et al., 2010; Maris 
et al., 2011). The differential modulation of cross-frequency 
components by condition supports this view: component load-
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GABRA2 alleles (see Figure 6F) would receive the greatest benefit 
from this type of pharmacological intervention.
lIMItatIons and future work
The results presented here must be interpreted in the context of 
several methodological limitations. First, because our analysis com-
bined data from a number of related studies and constitutes a “con-
venience sample,” demographics were not well matched between 
HC and SZ groups, particularly with regard to age. We attempted to 
correct for this difference by linearly regressing age from depend-
ent variables prior to group comparisons, however distinctions in 
modulation patterns between HC and SZ may still be impacted 
by age. To see if this was the case, we compared the original ICM 
loading parameters in a subset of age-matched SZ (n = 42) and 
HC (n = 42; HC age: 36.1 ± 11.4; SZ age: 36.2 ± 11.6, t82 = 0.03, 
P = 0.97), and found that the group differences persisted (ICM 1: 
F = 4.16, P < 0.05; ICM 4: F = 8.46, P < 0.005). While this suggests 
that age is not the sole factor contributing to the group difference, 
future investigations should use better-matched groups to address 
this issue and other possible confounds.
A second limitation is the possible effect of medication. As with 
any study of a clinical population, our findings may be influenced by 
the medication status of patients at the time of evaluation as well as 
life-long medication history. Here, there is a particular concern that 
prescribed antipsychotic medications often target the dopamine 
receptors identified in our genetic association analysis. While our 
patient sample size is too small (and available medication informa-
tion too sparse) to fully assess these possible confounds, we have 
attempted to address concerns with what information we do have. 
Regarding the main effect of cfM group differences, the loading 
parameters of schizophrenia-relevant cfM components ICM 1 and 
ICM 4 are not significantly different between SZ patients taking 
(35/47) and those not taking antipsychotics (12/47) at the time 
of assessment (two-tailed t-test, ICM 1: t45 = 0.95, P =  0.34; ICM 
4: t45 = −0.31, P =  0.76; permutation test, ICM 1: P =  0.65; ICM 4: 
P = 0.24; 10,000 permutations). Also, as described above, subjects 
with first-degree SZ relatives (REL) exhibited patterns of cfM that 
were intermediate between HC and SZ. Regarding the genetic asso-
ciation findings, both HC and SZ show the same trend between 
DRD2 genotype and the loading parameters of ICM 1 (Figure 6C 
and related text), implying that medication does not affect this rela-
tionship. Additionally, for SZ patients with genotype data (36/47), 
we found no difference in cfM-associated genetic components 
between patients taking (28/36) and not taking antipsychotics 
(8/36). This was true whether we examined the loading parameters 
of genetic components (two-tailed t-test, ICG 6: t34 = 1.01, P = 0.32; 
ICG 4: t34 = −0.54, P = 0.52; permutation test, ICG 6: P = 0.69, ICG 4: 
P = 0.48) or the genotype distributions directly (rs6277: χ2 = 1.46, 
P = 0.48; rs279869: χ2 = 0.56, P = 0.76). These analyses support an 
interpretation that findings are not completely due to medication 
status, though we again note that with such small samples we lack 
sufficient statistical power to perform a conclusive investigation 
and the influence of medication must be addressed in future work.
A third limitation is the ability to detect and quantify cfM. 
Most previous studies have used intra-cranial recordings 
(though see e.g., Demiralp et al., 2007; Osipova et al., 2008) to 
noted   significant differences in task performance between the sub-
ject groups (see Table 1), and while the strength of cfM did not 
directly correlate with any recorded measures of task performance 
(see Results), we cannot rule out the possibility that group effects 
are related to differences in attentional engagement or behavioral 
responses to the AOD task. Future studies should to investigate pat-
terns of cfM while subjects are resting or engaged in other behaviors. 
It will also be important to determine whether distinctions in cfM are 
specific to schizophrenia patients, or whether they represent a more 
general marker of altered neural coordination that may common to 
other neuropsychiatric disorders (Herrmann and Demiralp, 2005).
Genetic association analysis identified several SNPs co-varying 
with schizophrenia-relevant cfM components. It is interesting 
to note that none showed a direct association with diagnosis in 
the same set of subjects (see Table 2), supporting the biomarker 
approach toward elucidating the genetics of complex disorders 
(Braff et al., 2007). While this study is the first to identify genetic 
contributions to cross-frequency coupling, it complements a large 
body of work demonstrating genetic influences on cortical oscilla-
tions (Begleiter and Porjesz, 2006). Investigations of event-related 
potentials and resting-state dynamics implicate many genes within 
dopaminergic, adrenergic, cholinergic, GABAergic and glutamater-
gic pathways (Begleiter and Porjesz, 2006; Liu et al., 2009a).
In the current study, we observed an association between the 
magnitude of global cfM (ICM 1) and the rs6277 genotype. The 
rs6277 polymorphism, also known as C957T, is a synonymous 
mutation in exon 7 of the DRD2 gene. In both patients and con-
trols, the strength of cross-frequency coupling decreased with 
copies of the 957C allele. Consistent with the suggested role 
of cfM in neural coordination, presence of the 957C allele has 
been associated with poorer performance on executive function 
(Rodriguez-Jimenez et al., 2006), working memory (Jacobsen 
et al., 2006), and avoidance learning (Frank and Hutchison, 2009) 
in healthy controls. Furthermore, several case-control association 
studies have supported an over-representation of the 957C allele 
in schizophrenia (Lawford et al., 2005; Hänninen et al., 2006; 
Betcheva et al., 2009).
We also found an association between the weights of cfM com-
ponent 4 and several SNPs within/near the GABRA2 gene; these 
were intronic (rs279869, rs279837), synonymous (rs279858), or 
in flanking regions of DNA (rs567926). Though their functional 
effects are unknown, these SNPs (or others in high LD) may affect 
the expression of the GABAA receptor (Ittiwut et al., 2007). Because 
correlations between GABRA2 genotypes and ICM 4 were observed 
only in SZ (see Figure 6E, Figure A2B), the GABRA2 genotype 
may only affect cross-frequency coupling only when neuronal cir-
cuitry is altered. Evidence of diminished GABAergic transmission 
in schizophrenia patients (Lewis et al., 2005; Bullock et al., 2008) 
supports this conjecture. Differences include decreased expression 
of enzymes regulating GABA synthesis and re-uptake, and com-
pensatory increased expression of post-synaptic GABAA, α2 subu-
nit receptors (Lewis et al., 2005). Recently, the use of α2 selective 
GABAA agonists to normalize GABAergic tone has been proposed, 
with preliminary evidence of improved cognitive function during 
treatment (Lewis et al., 2008). Our findings make important pre-
dictions regarding the success of these clinical trials, as they imply 
that the therapeutic effects of GABAA agonists will be stratified over 
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FiGuRE A1 | Correlation structure for the genotyped polymorphisms. (A,B) 
r2 values computed between all pairs of loci. High correlations indicate data 
redundancy, which is reduced through ICA. Polymorphic loci in close physical 
proximity are bounded with black boxes. Correlation structure is displayed for all 
subjects in (A), and in (B) is computed separately for the 3 largest subsets of 
subjects identifying as Caucasian (left, n = 118), African American (middle, 
n = 21), and Hispanic (right, n = 16). Correlation structure is similar between 
groups, though differences in magnitude are evident.
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Genetic component association results, including race in the regression model. 
Plot of the negative natural logarithm of the P-values for the regression models 
between each of the 16 genetic components and cfM components 1 (Left) and 4 
(Right). The pink shaded region indicates the uncorrected P-values for the full 
model, while the black, white, and blue regions show the P-values for the genetic, 
genetic × diagnosis, and race terms, respectively. Asterisks denote significant 
models between (1) ICM 1 and ICG 6 (Left, pink; F4,165 = 4.88, P < 0.001), (2) ICM 4 
and ICG 6 (Right, pink; F4,165 = 7 .18, P < 0.00005), and (3) ICM 4 and ICG 4 (Right, 
pink; F4,165 = 6.23, P < 0.0005). Associations were all significant at P < 0.05 after 
Bonferroni correction for 32 tests. Examination of the individual beta weights 
revealed a main effect of genetic component 6 on ICM 1 (Left, black; t165 = 3.05, 
P < 0.005). Associations with ICM 4 were both due to interactions between the 
genetic components and the diagnosis (Right, white; t165 = 3.30, P < 0.005 and 
t165 = 3.18, P < 0.005 for ICG 6 and ICG 4, respectively). No significant associations 
with race were found. (B) Plots of modulation component loading parameters as a 
function of GABRA2 genotype. Data is stratified by SZ (red) and HC (blue) to 
highlight group × diagnosis interactions. Error bars denote ± 1 SEM. Dashed line 
shows the least-squares linear fit to the data. The number of individuals with each 
genotype is indicated adjacent to the data marker.
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